We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$5.44B
AUM Growth
-$517M
Cap. Flow
-$1.1B
Cap. Flow %
-20.26%
Top 10 Hldgs %
16.51%
Holding
1,406
New
141
Increased
183
Reduced
106
Closed
202

Top Buys

Rank Stock Value
1
AXP icon
American Express
AXP
+$60M
2
ALL icon
Allstate
ALL
+$46.9M
3
WFC icon
Wells Fargo
WFC
+$45.7M
4
NI icon
NiSource
NI
+$41.1M
5
BNY
Bank of New York Mellon
BNY
+$41M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$264M
2
TSM icon
TSMC
TSM
+$179M
3
CCMP
CMC Materials, Inc. Common Stock
CCMP
+$93.4M
4
COHR
Coherent Inc
COHR
+$73.9M
5
MSFT icon
Microsoft
MSFT
+$42.8M

Sector Composition

Rank Sector Weight
1 Technology 13.28%
2 Financials 12.39%
3 Healthcare 3.91%
4 Consumer Discretionary 3.9%
5 Communication Services 3.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSTX
1076
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$36K ﹤0.01%
10,258
– –
ATOS icon
1077
Atossa Therapeutics
ATOS
$22.9M
$35K ﹤0.01%
2,782
– –
CTMX icon
1078
CytomX Therapeutics
CTMX
$727M
$34K ﹤0.01%
23,134
– –
CUE icon
1079
Cue Biopharma
CUE
$133M
$33K ﹤0.01%
488
– –
LENZ
1080
LENZ Therapeutics
LENZ
$175M
$33K ﹤0.01%
1,504
– –
SPPI
1081
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$33K ﹤0.01%
77,541
– –
GAN
1082
DELISTED
GAN Ltd
GAN
$32K ﹤0.01%
14,310
– –
STXS icon
1083
Stereotaxis
STXS
$132M
$32K ﹤0.01%
17,703
– –
FBIO icon
1084
Fortress Biotech
FBIO
$114M
$30K ﹤0.01%
2,326
– –
LAB icon
1085
Standard BioTools
LAB
$327M
$30K ﹤0.01%
27,176
– –
PAVM icon
1086
PAVmed
PAVM
$35.9M
$30K ﹤0.01%
77
– –
ADVM
1087
DELISTED
Adverum Biotechnologies
ADVM
$29K ﹤0.01%
3,099
– –
KOPN icon
1088
Kopin
KOPN
$699M
$29K ﹤0.01%
27,682
– –
REE
1089
DELISTED
REE Automotive
REE
$29K ﹤0.01%
+1,427
New +$49.1K
CLOER
1090
DELISTED
Clover Leaf Capital Corp. Rights
CLOER
$28K ﹤0.01%
620,000
– –
PBYI icon
1091
Puma Biotechnology
PBYI
$411M
$27K ﹤0.01%
11,514
– –
NNBR icon
1092
NN Inc
NNBR
$278M
$26K ﹤0.01%
15,246
– –
VHC icon
1093
VirnetX Holding Corp
VHC
$51M
$26K ﹤0.01%
1,131
– –
CRVS icon
1094
Corvus Pharmaceuticals
CRVS
$1.11B
$25K ﹤0.01%
30,000
– –
NEUE
1095
DELISTED
NeueHealth
NEUE
$25K ﹤0.01%
292
– –
LITS
1096
Lite Strategy Inc
LITS
$34.4M
$24K ﹤0.01%
3,041
– –
QTTB icon
1097
Q32 Bio
QTTB
$481M
$24K ﹤0.01%
831
– –
DTIL icon
1098
Precision BioSciences
DTIL
$192M
$23K ﹤0.01%
601
– –
IMDX
1099
Insight Molecular Diagnostics
IMDX
$154M
$23K ﹤0.01%
1,573
– –
PPTA
1100
Perpetua Resources
PPTA
$2.28B
$23K ﹤0.01%
11,589
– –
42 43
44
45 46

Similar funds

Wealthfront Advisers
Wealthfront Advisers Palo Alto, California $45.6B AUM 18.83% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
Zurich Cantonal Bank
Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AS
Akuna Securities Chicago, Illinois $44.1B AUM 15.47% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

LMR Partners's Q3 2022 Portfolio in Review

As of Q3 2022, LMR Partners held 1,406 positions worth $5.44B, down 8.7% from $5.96B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

LMR Partners withdrew a net $1.1B in Q3 2022, closing 202 positions and reducing 106 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $264M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, LMR Partners opened a new position in Allstate worth $47M.

  • LMR Partners's largest Q3 2022 buy was Allstate: 377,327 shares worth $47M.
  • LMR Partners added most to American Express in Q3 2022, an estimated $60M increase.
  • LMR Partners's biggest Q3 2022 reduction was TSMC, cutting an estimated $179M.
  • LMR Partners fully exited State Street SPDR S&P 500 ETF Trust in Q3 2022, selling an estimated $264M.
  • LMR Partners's ten largest holdings make up 17% of its $5.44B portfolio in Q3 2022.
  • LMR Partners opened 141 new positions and closed 202 in Q3 2022.
  • LMR Partners's portfolio value fell 8.7% quarter-over-quarter to $5.44B.

Based on LMR Partners's 13F filing for Q3 2022, filed 14 Nov 2022.